Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre-Yves LE Roux

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Thrombosis Research|December 3, 2014
Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolismPierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
Nuclear Medicine Communications|April 17, 2013
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinomaRonan Abgral, Pierre-Yves Le Roux, Jean Rousset, et al.
BMJ Open|April 23, 2018
SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcomePierre-Yves Le Roux, Philippe Robin, Cécile Tromeur, et al.
Frontiers in Immunology|May 4, 2026
Case Report: Complete metabolic responses to trastuzumab-deruxtecan in HER2-altered solid tumors: two illustrative casesColine Le Meur, Pierre-Yves Le Roux, Pierre Alemany, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2014
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatmentPhilippe Robin, Ronan Abgral, Gérald Valette, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinomaRonan Abgral, Nathalie Keromnes, Philippe Robin, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 8, 2022
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteriaNaelle Lombion, Philippe Robin, Adrian Tempescul, et al.
EJNMMI Research|July 30, 2020
Correlation of positron emission tomography ventilation-perfusion matching with CT densitometry in severe emphysemaAsha Bonney, Carrie-Anne Wagner, Shankar Siva, et al.
Seminars in Thrombosis and Hemostasis|April 9, 2025
Prediction of Recurrent Venous Thromboembolism and Arterial Cardiovascular Events after Discontinuation of Anticoagulation: The R-VTE-predict and MACE-predict Risk ScoresSteve R Noumegni, Benjamin Espinasse, Romain Didier, et al.
Nuclear Medicine Communications|March 24, 2012
Diagnosis of pulmonary embolism: planar images generated from V/Q SPECT are not a reliable substitute for traditional planar V/Q scanPierre-Yves Le Roux, Ronan Abgral, Morgan Jaffrelot, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Thrombosis Research|December 3, 2014
Performance of 18F fluoro-2-désoxy-D-glucose positron emission tomography/computed tomography for the diagnosis of venous thromboembolismPierre-Yves Le Roux, Philippe Robin, Aurélien Delluc, et al.
Nuclear Medicine Communications|April 17, 2013
Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinomaRonan Abgral, Pierre-Yves Le Roux, Jean Rousset, et al.
BMJ Open|April 23, 2018
SPECT V/Q for the diagnosis of pulmonary embolism: protocol for a systematic review and meta-analysis of diagnostic accuracy and clinical outcomePierre-Yves Le Roux, Philippe Robin, Cécile Tromeur, et al.
Frontiers in Immunology|May 4, 2026
Case Report: Complete metabolic responses to trastuzumab-deruxtecan in HER2-altered solid tumors: two illustrative casesColine Le Meur, Pierre-Yves Le Roux, Pierre Alemany, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2014
Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatmentPhilippe Robin, Ronan Abgral, Gérald Valette, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 8, 2013
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinomaRonan Abgral, Nathalie Keromnes, Philippe Robin, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|February 8, 2022
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteriaNaelle Lombion, Philippe Robin, Adrian Tempescul, et al.
EJNMMI Research|July 30, 2020
Correlation of positron emission tomography ventilation-perfusion matching with CT densitometry in severe emphysemaAsha Bonney, Carrie-Anne Wagner, Shankar Siva, et al.
Seminars in Thrombosis and Hemostasis|April 9, 2025
Prediction of Recurrent Venous Thromboembolism and Arterial Cardiovascular Events after Discontinuation of Anticoagulation: The R-VTE-predict and MACE-predict Risk ScoresSteve R Noumegni, Benjamin Espinasse, Romain Didier, et al.
Nuclear Medicine Communications|March 24, 2012
Diagnosis of pulmonary embolism: planar images generated from V/Q SPECT are not a reliable substitute for traditional planar V/Q scanPierre-Yves Le Roux, Ronan Abgral, Morgan Jaffrelot, et al.
Pageof 11